OLBA HEALTHCARE HOLDINGS Past Earnings Performance
Past criteria checks 2/6
OLBA HEALTHCARE HOLDINGS has been growing earnings at an average annual rate of 21.5%, while the Healthcare industry saw earnings growing at 6% annually. Revenues have been growing at an average rate of 0.9% per year. OLBA HEALTHCARE HOLDINGS's return on equity is 13.8%, and it has net margins of 1.3%.
Key information
21.5%
Earnings growth rate
20.1%
EPS growth rate
| Healthcare Industry Growth | 7.9% |
| Revenue growth rate | 0.9% |
| Return on equity | 13.8% |
| Net Margin | 1.3% |
| Last Earnings Update | 31 Mar 2024 |
Recent past performance updates
Revenue & Expenses BreakdownBeta
How OLBA HEALTHCARE HOLDINGS makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 31 Mar 24 | 117,022 | 1,496 | 11,293 | 0 |
| 31 Dec 23 | 114,220 | 1,353 | 11,165 | 0 |
| 30 Sep 23 | 111,660 | 1,331 | 10,979 | 0 |
| 30 Jun 23 | 110,472 | 1,414 | 10,810 | 0 |
| 31 Mar 23 | 109,055 | 1,435 | 10,791 | 0 |
| 31 Dec 22 | 108,647 | 1,550 | 10,634 | 0 |
| 30 Sep 22 | 109,253 | 1,611 | 10,498 | 0 |
| 30 Jun 22 | 107,959 | 1,535 | 10,430 | 0 |
| 31 Mar 22 | 108,804 | 1,239 | 10,194 | 0 |
| 31 Dec 21 | 110,724 | 1,132 | 10,164 | 0 |
| 30 Sep 21 | 111,880 | 1,110 | 10,106 | 0 |
| 30 Jun 21 | 112,976 | 989 | 10,058 | 0 |
| 31 Mar 21 | 109,884 | 750 | 9,937 | 0 |
| 31 Dec 20 | 107,631 | 546 | 9,892 | 0 |
| 30 Sep 20 | 105,651 | 137 | 10,162 | 0 |
| 30 Jun 20 | 107,896 | 326 | 10,140 | 0 |
| 31 Mar 20 | 110,131 | 628 | 10,176 | 0 |
| 31 Dec 19 | 108,594 | 573 | 10,173 | 0 |
| 30 Sep 19 | 111,010 | 1,025 | 9,833 | 0 |
| 30 Jun 19 | 107,428 | 775 | 9,835 | 0 |
| 31 Mar 19 | 106,290 | 679 | 9,900 | 0 |
| 31 Dec 18 | 107,481 | 830 | 9,898 | 0 |
| 30 Sep 18 | 106,208 | 843 | 9,864 | 0 |
| 30 Jun 18 | 107,663 | 1,054 | 9,787 | 0 |
| 31 Mar 18 | 107,283 | 1,010 | 9,807 | 0 |
| 31 Dec 17 | 107,157 | 908 | 9,786 | 0 |
| 30 Sep 17 | 106,546 | 874 | 9,809 | 0 |
| 30 Jun 17 | 105,778 | 690 | 9,854 | 0 |
| 31 Mar 17 | 104,916 | 668 | 9,698 | 0 |
| 31 Dec 16 | 105,406 | 591 | 9,656 | 0 |
| 30 Sep 16 | 103,816 | 397 | 9,623 | 0 |
| 30 Jun 16 | 101,460 | 305 | 9,592 | 0 |
| 31 Mar 16 | 101,177 | 441 | 9,433 | 0 |
| 31 Dec 15 | 98,108 | 381 | 9,364 | 0 |
| 30 Sep 15 | 95,150 | 320 | 9,249 | 0 |
| 30 Jun 15 | 94,515 | 405 | 9,090 | 0 |
| 31 Mar 15 | 91,089 | 212 | 9,082 | 0 |
| 31 Dec 14 | 94,825 | 551 | 8,959 | 0 |
| 30 Sep 14 | 95,699 | 612 | 8,823 | 0 |
| 30 Jun 14 | 97,137 | 816 | 8,680 | 0 |
| 31 Mar 14 | 99,942 | 884 | 8,757 | 0 |
| 31 Dec 13 | 97,755 | 853 | 8,684 | 0 |
| 30 Sep 13 | 97,753 | 1,058 | 8,620 | 0 |
| 30 Jun 13 | 96,223 | 943 | 8,519 | 0 |
Quality Earnings: 2689 has high quality earnings.
Growing Profit Margin: 2689's current net profit margins (1.3%) are lower than last year (1.3%).
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: 2689's earnings have grown significantly by 21.5% per year over the past 5 years.
Accelerating Growth: 2689's earnings growth over the past year (4.3%) is below its 5-year average (21.5% per year).
Earnings vs Industry: 2689 earnings growth over the past year (4.3%) did not outperform the Healthcare industry 8.4%.
Return on Equity
High ROE: 2689's Return on Equity (13.8%) is considered low.